Zobrazeno 1 - 10
of 111
pro vyhledávání: '"Damien Thomson"'
Autor:
Guy C. Toner, Howard Gurney, M. Rosenthal, Mark D. Chatfield, Peter Grimison, Baerin Houghton, Martin R. Stockler, Michael Friedlander, Felicia Roncolato, Damien Thomson
Publikováno v:
Internal Medicine Journal. 46:893-898
Background/AimThe utility of pulmonary function testing (PFT) to detect bleomycin-induced pneumonitis is controversial. We describe its impact on bleomycin dosing in a phase 2 trial of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced ge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72a78ed97edc3e9eede8cf555903e8a6
https://doi.org/10.1111/imj.13158
https://doi.org/10.1111/imj.13158
Autor:
Martin R. Stockler, Amy L. Boland, Damien Thomson, Peter Grimison, A. McDonald, New Zealand Urogenital, N. Singhal, Guy C. Toner, Brent O'Carrigan, C. Underhill, Fritha J. Hanning, Ian D. Davis, Hayley S. Whitford, P. Clingan, Ian N. Olver, M. Fournier
Publikováno v:
Internal Medicine Journal. 44:813-817
This is the first prospective study in a contemporary Australian/New Zealand population to determine the prevalence of testosterone deficiency in testicular cancer survivors at 12 months from treatment, and any association with poorer quality of life
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a4e448fd975cf1aa0d5c70c977835d6
https://doi.org/10.1111/imj.12500
https://doi.org/10.1111/imj.12500
Autor:
Damien Thomson, Paul Vasey, Nimit Singhal, Craig R. Lewis, Michael Friedlander, Martin R. Stockler, M. Rosenthal, Sarah E. Wong, Ganessan Kichenadasse, Peter Grimison, Howard Gurney, Nicola Jane Lawrence, Annie Yeung, Guy C. Toner, Luke Buizen, Val Gebski, Nicole Wong, Andrew J. Martin
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 27(12)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f414e272e9a2216f55d204b2ad4a3579
https://pubmed.ncbi.nlm.nih.gov/27502724
https://pubmed.ncbi.nlm.nih.gov/27502724
Autor:
Mark R Middleton, R Anderson, Axel Hauschild, Kurt R. Gehlsen, Peter Naredi, S Burdette-Radoux, Kristoffer Hellstrand, Damien Thomson
BACKGROUND: The safety and efficacy of immunotherapy with histamine dihydrochloride (HDC), interleukin-2 (IL-2) and interferon-alpha2b (IFN) compared with dacarbazine (DTIC) in adult patients with stage IV melanoma was evaluated. PATIENTS AND METHODS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e0dcd07d585d7aa5bfb4ecea59652cf
https://ora.ox.ac.uk/objects/uuid:2fcdf652-328f-48eb-8e63-9c43e3689c57
https://ora.ox.ac.uk/objects/uuid:2fcdf652-328f-48eb-8e63-9c43e3689c57
Autor:
Bryan Burmeister, Andrew Barbour, Euan Walpole, Damien Thomson, John E. Thomas, Elizabeth Burmeister, David C. Gotley, Jennifer Harvey, Bernard Mark Smithers
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 4:A29-A83
Preoperative chemotherapy (CT) and preoperative chemoradiation therapy (CRT) for resectable oesophageal cancer have both been shown to improve overall survival in meta-analyses. However there are no trials comparing these adjuvant therapies with each
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95699122fe6be9c71d59878301439905
https://doi.org/10.1111/j.1743-7563.2008.00201_1.x
https://doi.org/10.1111/j.1743-7563.2008.00201_1.x
Autor:
David C. Gotley, Andrew Barbour, Janine Thomas, Mark Jones, Damien Thomson, Mithat Gonen, B. Mark Smithers, Bryan Burmeister
Publikováno v:
Annals of Surgical Oncology. 15:2894-2902
Accurate staging is vital for esophageal cancer management. The utility of the American Joint Committee on Cancer (AJCC) staging system 6th edition for esophageal cancer has been questioned for resected patients who receive neoadjuvant chemoradiother
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70a05409e990734a0dec116322df36f3
https://doi.org/10.1245/s10434-008-0084-y
https://doi.org/10.1245/s10434-008-0084-y
Autor:
Ian Martin, Euan Walpole, Damien Thomson, Andrew Barbour, Bernard Mark Smithers, Jennifer Harvey, David C. Gotley, Mary P. Cullinan, Janine Thomas, Bryan Burmeister
Publikováno v:
Diseases of the Esophagus. 20:471-477
Chemoradiotherapy (CRT) as a definitive treatment for esophageal cancer, is being used with increasing frequency and as a result, surgeons will be required to assess more patients who have residual or recurrent local malignancy. This article aimed to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6e728f2cc692aa6802f9e73b75b2461
https://doi.org/10.1111/j.1442-2050.2007.00701.x
https://doi.org/10.1111/j.1442-2050.2007.00701.x
Autor:
Karen A. Herzig, David Nicol, James J.B. Petrie, Helen G. Juffs, Ralph Cobcroft, Devinder Gill, Allison M. Brown, Damien Thomson, David W. Johnson, Scott B. Campbell, Paula Marlton, Carmel M. Hawley, Debra Norris
Publikováno v:
Transplant International. 16:529-536
Post-transplant lymphoproliferative disorder (PTLD) complicates 1 to 10% of all transplantations. Previous clinicopathological studies of PTLD have been limited by small numbers, short follow-up times, outdated data, heterogeneity of pooled solid-org
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06566a1811a41e53bde07b1fc7233bda
https://doi.org/10.1007/s00147-003-0596-0
https://doi.org/10.1007/s00147-003-0596-0
Autor:
John E. Thomas, Damien Thomson, K. H. Lim, Bernard Mark Smithers, Jennifer Harvey, Ian Martin, David C. Gotley, Euan Walpole, Bryan Burmeister, Wendy A. Brown
Publikováno v:
ANZ Journal of Surgery. 73:A61-A72
Purpose A subset of patients with oesophageal cancer will have a complete response to neoadjuvant therapy. These patients have a greatly improved survival over nonresponders. By selecting only those who have a response to neoadjuvant therapy for surg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca83370e3a38c7de8072f313a36bba47
https://doi.org/10.1111/j.1445-2197.2003.00009.x
https://doi.org/10.1111/j.1445-2197.2003.00009.x
Autor:
Glen A Kennedy, Paula Marlton, Siok-Keen Tey, Karen Grimmett, Ralph Cobcroft, Gavin Cull, Devinder Gill, Damien Thomson
Publikováno v:
British Journal of Haematology. 119:412-416
Re-treatment with rituximab for B-cell non-Hodgkin's lymphoma (NHL) relapsing after previous rituximab therapy has recently been shown to be clinically efficacious. Although the mechanism of resistance to rituximab re-treatment in non-responding pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c14263687982e804ae15342f527f5c41
https://doi.org/10.1046/j.1365-2141.2002.03843.x
https://doi.org/10.1046/j.1365-2141.2002.03843.x